J

Jafron Biomedical Co Ltd
SZSE:300529

Watchlist Manager
Jafron Biomedical Co Ltd
SZSE:300529
Watchlist
Price: 29.87 CNY -4.57% Market Closed
Market Cap: 24.1B CNY
Have any thoughts about
Jafron Biomedical Co Ltd?
Write Note

Cash Flow Statement

Cash Flow Statement
Jafron Biomedical Co Ltd

Rotate your device to view
Cash Flow Statement
Currency: CNY
Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024
Operating Cash Flow
Cash Taxes Paid
(112)
(123)
(127)
(129)
(124)
(130)
(138)
(150)
(169)
(178)
(192)
(208)
(223)
(233)
(242)
(253)
(276)
(267)
(284)
(315)
(298)
(344)
(365)
(384)
(428)
(482)
(460)
(499)
(442)
(369)
(330)
(237)
(256)
(265)
(364)
Change in Working Capital
(190)
(201)
(212)
(218)
(222)
(224)
(219)
(245)
(250)
(287)
(312)
(348)
(380)
(423)
(456)
(460)
(544)
(509)
(527)
(605)
(623)
(691)
(739)
(749)
(753)
(818)
(908)
(961)
(1 027)
(996)
(1 011)
(944)
(877)
(879)
(901)
Cash from Operating Activities
205
N/A
195
-5%
192
-2%
182
-5%
179
-2%
205
+15%
283
+38%
293
+4%
304
+4%
308
+1%
317
+3%
321
+1%
384
+20%
423
+10%
465
+10%
541
+16%
584
+8%
640
+10%
669
+4%
697
+4%
958
+37%
1 043
+9%
1 110
+6%
1 129
+2%
1 249
+11%
1 143
-9%
1 206
+6%
1 108
-8%
875
-21%
995
+14%
872
-12%
949
+9%
917
-3%
1 185
+29%
1 229
+4%
Investing Cash Flow
Capital Expenditures
(61)
(57)
(47)
(37)
(29)
(24)
(68)
(119)
(178)
(183)
(156)
(194)
(174)
(208)
(230)
(223)
(221)
(220)
(238)
(255)
(357)
(489)
(535)
(579)
(537)
(509)
(536)
(520)
(476)
(365)
(263)
(159)
(247)
(308)
(303)
Other Items
(1)
0
0
(200)
(98)
(497)
5
(580)
118
527
(55)
741
(81)
(85)
(25)
(976)
24
(280)
45
566
16
321
9
(465)
(133)
24
29
924
170
14
17
19
(2)
(754)
(999)
Cash from Investing Activities
(62)
N/A
(57)
+8%
(47)
+18%
(237)
-407%
(126)
+47%
(521)
-312%
(63)
+88%
(699)
-1 019%
(59)
+92%
345
N/A
(211)
N/A
547
N/A
(255)
N/A
(293)
-15%
(255)
+13%
(1 199)
-370%
(197)
+84%
(500)
-154%
(192)
+62%
311
N/A
(341)
N/A
(168)
+51%
(526)
-212%
(1 044)
-99%
(670)
+36%
(485)
+28%
(507)
-4%
404
N/A
(306)
N/A
(351)
-15%
(246)
+30%
(140)
+43%
(250)
-78%
(1 062)
-325%
(1 302)
-23%
Financing Cash Flow
Net Issuance of Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
195
0
0
0
67
0
0
0
0
0
0
Net Issuance of Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
998
998
998
0
0
170
296
625
741
601
418
215
(19)
Cash Paid for Dividends
0
0
0
0
0
0
(76)
(76)
(83)
0
(133)
(133)
(146)
0
(271)
(271)
(251)
0
(378)
(378)
(378)
0
(531)
(531)
(531)
0
(720)
(720)
(729)
(735)
(560)
(567)
(562)
(562)
(341)
Other
(89)
0
0
422
421
560
560
137
140
17
9
9
32
17
74
79
56
0
113
111
65
0
147
(142)
(497)
(299)
(485)
(202)
(0)
64
(68)
(193)
(309)
(522)
(504)
Cash from Financing Activities
(89)
N/A
0
N/A
0
N/A
422
N/A
421
0%
560
+33%
483
-14%
61
-87%
56
-7%
(66)
N/A
(124)
-88%
(123)
+0%
(115)
+7%
(129)
-12%
(198)
-54%
(192)
+3%
(195)
-2%
0
N/A
(265)
N/A
(267)
-1%
(313)
-17%
0
N/A
614
N/A
325
-47%
165
-49%
169
+2%
(1 205)
N/A
(752)
+38%
(366)
+51%
(45)
+88%
113
N/A
(159)
N/A
(452)
-184%
(869)
-92%
(864)
+1%
Change in Cash
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
0
0
0
1
1
(0)
(0)
(1)
(1)
0
0
0
Net Change in Cash
55
N/A
82
+51%
89
+9%
367
+311%
473
+29%
243
-49%
703
+189%
(346)
N/A
301
N/A
586
+95%
(18)
N/A
745
N/A
15
-98%
1
-93%
12
+1 018%
(850)
N/A
191
N/A
(57)
N/A
212
N/A
741
+250%
303
-59%
561
+85%
1 199
+114%
410
-66%
744
+82%
826
+11%
(506)
N/A
762
N/A
203
-73%
599
+194%
738
+23%
648
-12%
215
-67%
(746)
N/A
(936)
-25%
Free Cash Flow
Free Cash Flow
144
N/A
138
-4%
145
+5%
145
0%
150
+4%
181
+21%
215
+19%
173
-19%
126
-27%
125
-1%
161
+29%
127
-21%
211
+65%
215
+2%
236
+9%
319
+35%
363
+14%
421
+16%
431
+2%
441
+2%
600
+36%
554
-8%
575
+4%
550
-4%
712
+29%
634
-11%
670
+6%
589
-12%
399
-32%
630
+58%
609
-3%
790
+30%
669
-15%
877
+31%
926
+6%

See Also

Discover More